Clinical Trial Update: Mechanisms Underlying SGLT2i Kidney Effect in DKD Progression [NA]

View source ↗

Summary

This clinical trial update investigates the mechanisms by which SGLT2 inhibitors affect kidney outcomes in Diabetic kidney disease. The study status is not yet …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Kidney Disease

Snippet

Sponsor: Mario Negri Institute for Pharmacological Research | Conditions: Diabetic Kidney Disease (DKD) | NA | Status: NOT_YET_RECRUITING